(KZR) Kezar Life Sciences - Performance -49.8% in 12m
Compare KZR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-78.38%
#125 in Group
Rel. Strength
11.78%
#7020 in Universe
Total Return 12m
-49.82%
#108 in Group
Total Return 5y
-93.43%
#119 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -86.82%
14th Percentile in Group
12m Total Return: KZR (-49.8%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: KZR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for KZR
Total Return (including Dividends) | KZR | XBI | S&P 500 |
---|---|---|---|
1 Month | 2.49% | 11.81% | 13.81% |
3 Months | -32.24% | -13.61% | -6.30% |
12 Months | -49.82% | -12.29% | 10.65% |
5 Years | -93.43% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | KZR | XBI | S&P 500 |
1 Month | 34.4% | 72.9% | 83% |
3 Months | -85.7% | -83% | -75.3% |
12 Months | -46.5% | -51.6% | 50.1% |
5 Years | -69.7% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #134 | -8.33% | -9.95% |
3 Month | #130 | -21.6% | -27.7% |
12 Month | #108 | -42.8% | -54.7% |
5 Years | #123 | -91.3% | -96.8% |
FAQs
Does KZR Kezar Life Sciences outperforms the market?
No,
over the last 12 months KZR made -49.82%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months KZR made -32.24%, while XBI made -13.61%.
Over the last 3 months KZR made -32.24%, while XBI made -13.61%.
Performance Comparison KZR vs Indeces and Sectors
KZR vs. Indices KZR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -7.54% | -11.3% | -39.2% | -60.5% |
US NASDAQ 100 | QQQ | -7.73% | -14.9% | -39.4% | -61.5% |
US Dow Jones Industrial 30 | DIA | -7.95% | -7.50% | -38.9% | -57.5% |
German DAX 40 | DAX | -7.52% | -12.5% | -65.4% | -75.5% |
Shanghai Shenzhen CSI 300 | CSI 300 | -9.72% | -9.34% | -39.9% | -57.2% |
Hongkong Hang Seng | HSI | -10.7% | -17.4% | -47.5% | -63.5% |
India NIFTY 50 | INDA | -2.62% | -2.35% | -39.6% | -49.6% |
Brasil Bovespa | EWZ | -8.59% | -14.8% | -47.9% | -41.5% |
KZR vs. Sectors KZR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -8.18% | -10.9% | -46.2% | -71.4% |
Consumer Discretionary | XLY | -7.92% | -11.7% | -38.2% | -64.1% |
Consumer Staples | XLP | -6.68% | -4.10% | -46.1% | -58.9% |
Energy | XLE | -7.36% | -4.27% | -32.6% | -40.4% |
Financial | XLF | -8.64% | -11.0% | -46.3% | -72.3% |
Health Care | XLV | -4.53% | 1.62% | -34.2% | -45.8% |
Industrial | XLI | -9.23% | -14.3% | -40.6% | -60.8% |
Materials | XLB | -7.34% | -11.1% | -34.3% | -44.6% |
Real Estate | XLRE | -6.22% | -9.05% | -39.9% | -65.3% |
Technology | XLK | -8.62% | -18.7% | -36.3% | -56.9% |
Utilities | XLU | -7.59% | -7.10% | -46.8% | -67.3% |
Aerospace & Defense | XAR | -9.52% | -18.7% | -50.7% | -77.2% |
Biotech | XBI | -0.95% | -9.32% | -19.0% | -37.5% |
Homebuilder | XHB | -8.01% | -8.99% | -26.0% | -42.3% |
Retail | XRT | -9.44% | -12.2% | -34.9% | -48.3% |